XIAP and cancer: Interestingly, SM-164 compound was shown to decrease cIAP1 expression and to prevent XIAP binding to caspases without affecting XIAP expression [40], further stressing the point on a cancer line specific regulation of IAPs upon SMAC mimetic treatment.